<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aberrant proliferation, differentiation, and/or migration of progenitors observed in various <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> may be caused by defects in expression and/or function of integrins </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we have developed a new fluorescent beads <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> assay that facilitates flow cytometric investigation of lymphocyte function-associated antigen 1 (LFA-1)- and very late activation antigen-4 (VLA-4)-mediated functional <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> in B-lineage <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) of both the CD10(-) and CD10(+) (leukemic) cell population within one blood or bone marrow sample </plain></SENT>
<SENT sid="2" pm="."><plain>Surprisingly, of the 20 B-lineage ALL patients investigated, 17 contained a leukemic cell population with LFA-1- and/or VLA-4-mediated <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> defects </plain></SENT>
<SENT sid="3" pm="."><plain>Five patients contained CD10(+) cells that did not exhibit any LFA-1-mediated <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> due to the lack of LFA-1 surface expression </plain></SENT>
<SENT sid="4" pm="."><plain>The CD10(+) cells from 10 ALL patients expressed LFA-1 that could not be activated by the <z:chebi fb="0" ids="37532">phorbol ester</z:chebi> <z:chebi fb="0" ids="8116">phorbol</z:chebi> 12-<z:chebi fb="0" ids="30807">myristate</z:chebi> 13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="1" ids="53780">PMA</z:chebi>), whereas the CD10(-) cells expressed a functional LFA-1 </plain></SENT>
<SENT sid="5" pm="."><plain>Seven patients contained CD10(+) cells that expressed a <z:chebi fb="1" ids="53780">PMA</z:chebi>-unresponsive form of VLA-4 </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:chebi fb="1" ids="53780">PMA</z:chebi> unresponsiveness of the integrins LFA-1 and VLA-4 expressed by the CD10(+) cells may be due to mutations in the integrins itself, in protein kinases, or in other intracellular molecules involved in integrin <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These data clearly demonstrate the importance of investigating integrin function in addition to integrin surface expression </plain></SENT>
<SENT sid="8" pm="."><plain>The strikingly high frequency (85%) of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> defects in ALL could suggest a causal relationship between integrin-mediated <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and B-lineage ALL </plain></SENT>
</text></document>